Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01543997 · ClinicalTrials.gov registry record · Phase 2
Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms
A Phase 2 study of Sleep Disturbance and Persian Gulf War Syndrome in Veteran, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT01543997 is a Phase 2 study of Sleep Disturbance and Persian Gulf War Syndrome in Veteran that has completed, run by University of Utah. The registered enrollment target is 75 participants, below the 177-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01543997, a Phase 2 study of Sleep Disturbance and Persian Gulf War Syndrome in Veteran, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to investigate clinical benefits of a novel sleep-focused mind-body program on Gulf War Illness (GWI) symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Mind-Body Bridging Program
- BEHAVIORAL Supportive Education
Study Locations (2)
Utah
- Pain Research Center - Salt Lake City
- VA SLC Health Care System - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01543997
The ClinicalTrials.gov registry entry for NCT01543997 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (58% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Mind-Body Bridging Program is the first listed.
NCT01543997 reports 2 study locations spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01543997 about?
NCT01543997 is a clinical study titled "Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms". The purpose of this study is to investigate clinical benefits of a novel sleep-focused mind-body program on Gulf War Illness (GWI) symptoms.
What is the current status of trial NCT01543997?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2012-01. Estimated completion is 2016-05.
What conditions does trial NCT01543997 study?
This clinical trial studies the following conditions: Sleep Disturbance, Persian Gulf War Syndrome in Veteran.
What interventions are being tested in trial NCT01543997?
The interventions under investigation include: Mind-Body Bridging Program (BEHAVIORAL), Supportive Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01543997?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01543997 being conducted?
This trial has 2 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
RECRUITING · Phase 2
-
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease Risk
RECRUITING · Phase 2
-
RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
ACTIVE NOT RECRUITING · Phase 2
-
RECOVER-SLEEP: Platform Protocol
COMPLETED · Phase 2
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
-
Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.